ATE107663T1 - Synthetische peptidantigene zum nachweis von htlv-1-infektionen. - Google Patents

Synthetische peptidantigene zum nachweis von htlv-1-infektionen.

Info

Publication number
ATE107663T1
ATE107663T1 AT89904657T AT89904657T ATE107663T1 AT E107663 T1 ATE107663 T1 AT E107663T1 AT 89904657 T AT89904657 T AT 89904657T AT 89904657 T AT89904657 T AT 89904657T AT E107663 T1 ATE107663 T1 AT E107663T1
Authority
AT
Austria
Prior art keywords
infection
htlv
antigens
detecting htlv
peptid
Prior art date
Application number
AT89904657T
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Ab filed Critical Syntello Ab
Application granted granted Critical
Publication of ATE107663T1 publication Critical patent/ATE107663T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AT89904657T 1988-03-10 1989-03-10 Synthetische peptidantigene zum nachweis von htlv-1-infektionen. ATE107663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16620588A 1988-03-10 1988-03-10
US07/206,140 US5017687A (en) 1988-03-10 1988-06-13 Peptides for the detection of HTLV-1 infection

Publications (1)

Publication Number Publication Date
ATE107663T1 true ATE107663T1 (de) 1994-07-15

Family

ID=26862056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904657T ATE107663T1 (de) 1988-03-10 1989-03-10 Synthetische peptidantigene zum nachweis von htlv-1-infektionen.

Country Status (10)

Country Link
US (1) US5017687A (de)
EP (1) EP0403568B1 (de)
JP (1) JPH0751598B2 (de)
KR (1) KR900700507A (de)
AT (1) ATE107663T1 (de)
CA (1) CA1336529C (de)
DE (1) DE68916421T2 (de)
FI (1) FI904345A7 (de)
NZ (1) NZ228302A (de)
WO (1) WO1989008664A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5322769A (en) * 1988-03-11 1994-06-21 Abbott Laboratories Methods for using CKS fusion proteins
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
US5882853A (en) * 1989-09-01 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating HTLV-I-specific T cell responses
US5283320A (en) * 1989-11-13 1994-02-01 Syntello Ab Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
FI910245L (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections
AU641554B2 (en) * 1990-08-29 1993-09-23 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5378805A (en) * 1990-08-29 1995-01-03 United States Of America Immunoreactive HTLV-I/II ENV and POL peptides
WO1992007961A1 (en) * 1990-10-26 1992-05-14 President And Fellows Of Harvard College Specific detection of antibodies to human t-cell leukemia viruses
JP3421336B2 (ja) * 1991-07-10 2003-06-30 アボツト・ラボラトリーズ 合成ペプチドを用いてのｈｔｌｖ−▲ｉ▼とｈｔｌｖ−▲ｉｉ▼との区別
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
WO1993002102A1 (en) * 1991-07-23 1993-02-04 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5736378A (en) * 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
CA2117378C (en) * 1992-02-24 2003-04-15 Steven K. H. Foung Htlv-i/htlv-ii assay and method
SE9202318L (sv) * 1992-08-10 1994-02-11 Replico Medical Ab Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
AU6764196A (en) * 1995-08-31 1997-03-19 First Medical, Inc. Methods and antibodies for detecting creatine kinase
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US20050175583A1 (en) * 2003-12-02 2005-08-11 Lawrence Tamarkin Methods and compositions for the production of monoclonal antibodies
EP1715971A4 (de) * 2004-01-28 2010-10-13 Cytimmune Sciences Inc Funktionalisierte kolloidale metallzusammensetzungen und verfahren
WO2005076002A1 (ja) * 2004-02-06 2005-08-18 Kyowa Medex Co., Ltd. 抗体の測定方法
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
KR20100123674A (ko) * 2007-09-21 2010-11-24 싸이티뮨 사이언스, 인크. 나노치료제 콜로이드성 금속 조성물 및 방법
CA2706700A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028993A (ja) * 1983-07-22 1985-02-14 Otsuka Pharmaceut Co Ltd ヒト白血病ウイルス関連ペプチド
JPS60142925A (ja) * 1983-12-28 1985-07-29 Japan Found Cancer ヒト白血病ウイルス抗体の製造法
EP0152030A3 (de) * 1984-02-03 1986-08-13 Juridical Foundation Japanese Foundation for Cancer Research Adult-T-Zell-Leukemiavirus-Antigenpolypeptid
JPS60249058A (ja) * 1984-05-25 1985-12-09 Eisai Co Ltd Ａｔｌウイルス抗体の測定方法および試薬
US4722888A (en) * 1985-03-29 1988-02-02 United States Of America As Represented By The Department Of Health And Human Services Cell line producing human monoclonal antibody which binds to HTLV-I producing cells
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
EP0246101A3 (de) * 1986-05-14 1989-06-07 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Protein mit HTLV-I-antigener Aktivität und dessen Herstellung

Also Published As

Publication number Publication date
FI904345A0 (fi) 1990-09-03
DE68916421D1 (de) 1994-07-28
JPH0751598B2 (ja) 1995-06-05
JPH03503284A (ja) 1991-07-25
EP0403568A1 (de) 1990-12-27
EP0403568B1 (de) 1994-06-22
US5017687A (en) 1991-05-21
KR900700507A (ko) 1990-08-13
CA1336529C (en) 1995-08-01
WO1989008664A1 (en) 1989-09-21
DE68916421T2 (de) 1994-11-24
FI904345A7 (fi) 1990-09-03
NZ228302A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
ATE107663T1 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
DK268588D0 (da) Syntetisk peptidantigen til detektering af hiv-2-infektion
EP0284587A3 (de) Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen
BR9305435A (pt) Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
ATE149522T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
ATE179184T1 (de) Synthetische peptide, spezifisch zum nachweis von gegen hcv gerichteten antikörpern zur diagnose der hcv-infektion und zum vorkommen davon als impfstoffe
ATE116006T1 (de) Synthetische antigene zum nachweis von aids.
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE467690T1 (de) Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern
ATE147759T1 (de) Verfahren und materialien zum nachweis und therapie von hiv
FI102834B1 (fi) Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä
DE69012572D1 (de) Monoklonaler antikörper gegen acetylierte lysinabfälle in rekombinantem rindsomatotropin.
ATE281525T1 (de) Peptide zum nachweis von hiv-1-guppe o

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee